(Q43674663)

25 November 2017

A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss (English)

1 reference

25 November 2017

1 reference

1

1 reference

25 November 2017

Garsia R

2

1 reference

25 November 2017

1 August 2001

1 reference

International Journal of Andrology

25 November 2017

1 reference

25 November 2017

24

1 reference

25 November 2017

232-240

1 reference

25 November 2017

4

1 reference

Dietary intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral therapy 'Diet FRS Study'.

25 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Monitoring dietary change in a low-fat diet intervention study: advantages of using 24-hour dietary recalls vs food records

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Prognostic factors correlated with survival in AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Dietary intake and counseling, weight maintenance, and the course of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Treatments for wasting in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Atherogenic effects of anabolic steroids on serum lipid levels. A literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Hit HIV-1 hard, but only when necessary

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Total energy expenditure in human immunodeficiency virus-infected men and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Induction of adrenal suppression by megestrol acetate in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

"Buffalo hump" in men with HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Unusual distributions of body fat in AIDS patients: a review of adverse events reported to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Home parenteral nutrition in acquired immunodeficiency syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Megestrol acetate in patients with AIDS and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2605.2001.00291.X

10.1046/J.1365-2605.2001.00291.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference

PubMed ID

11454075